Daphne Hessels

Title: Innovations in Prostate Cancer Treatment by Daphne Hessels

Introduction

Daphne Hessels is an accomplished inventor based in Nijmegen, Netherlands. She has made significant contributions to the field of medical diagnostics, particularly in the area of prostate cancer. Her innovative work focuses on methods for predicting and treating clinically significant prostate cancer.

Latest Patents

Daphne Hessels holds a patent for a method that predicts and treats clinically significant prostate cancer. The invention relates to methods, devices, combinations, kits, and systems for analyzing urine samples from individuals suspected of having prostate cancer. This method is particularly effective for cases with a Gleason score of seven or more, especially in individuals with a serum prostate-specific antigen (sPSA) level lower than 15 ng/ml. The process involves determining mRNA expression levels of specific genes and normalizing these levels to establish the presence of clinically significant prostate cancer.

Career Highlights

Daphne is currently associated with Mdxhealth, a company that specializes in molecular diagnostics for cancer. Her work at Mdxhealth has been pivotal in advancing the understanding and treatment of prostate cancer through innovative diagnostic methods.

Collaborations

Daphne collaborates with notable colleagues, including Franciscus Petrus Smit and Jack A Schalken. Their combined expertise contributes to the development of effective diagnostic tools and treatment strategies for prostate cancer.

Conclusion

Daphne Hessels is a pioneering inventor whose work in prostate cancer diagnostics is making a significant impact in the medical field. Her innovative methods are paving the way for improved patient outcomes and advancing cancer treatment.